CIENA CORP reported revenue of $1.67B for the period ended 2026-08-01, +37.0% year on year. Net income was $0.27B, a 15.9% net margin on a 45.4% gross margin. The largest revenue line is Products at 83% of the total. Free cash flow for the period was $0.49B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $1.67B | +37.0% |
| Gross profit | $0.76B | — |
| Operating income | $0.30B | — |
| Net income | $0.27B | +429.6% |
| Gross margin | 45.4% | Net margin 15.9% |
| Revenue Q/Q | +6.4% | — |
| Segment | Revenue | Share |
|---|---|---|
| Products | $1.39B | 83.2% |
| Services | $0.28B | 16.8% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $0.91B | 54.6% |
| R&D | $0.24B | 14.2% |
| SG&A | $0.22B | 13.0% |
| Tax & other | $0.03B | 2.1% |
| Item | Amount |
|---|---|
| Total assets | $8.00B |
| Total liabilities | $4.94B |
| Shareholders' equity | $3.06B |
| Equity / assets | 38.2% |
| Operating cash flow | $0.68B |
| Capital expenditure | $0.19B |
| Free cash flow | $0.49B |
| Cash conversion (OCF / net income) | 171% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
CI ・ CINF ・ CTAS ・ CSCO ・ C ・ CFG ・ CLX ・ CME ・ CMS ・ KO ・ CTSH ・ COHR
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies